The fact that distinct signaling may be involved in pro- and anticancer properties of PPAR offers the hope to use successfully PPAR ligands in cancer therapy in combination with other active anticancer drugs that overcome the PPAR pro-oncogenic effects. Here, PPARA is linked to cancer.